More children vaccinated against mumps, measles, rubella and HPV The percentage of newborns participating in the immunisation programme targeting mumps, measles and rubella rose slightly over the past year.
Transfer models for harmful substances in animal feed online now RIVM and Wageningen Food Safety Research have made five feed-food transfer models available to calculate how many harmful substances in animal feed end up in animal-based foods.
Essential to keep a close eye on roll out of 5G The extent to which people are exposed to electromagnetic fields from individual 5G antennas and telephones is below the limits recommended by the European Union.
Control measures against the spread of Legionella from wastewater treatment plants Wastewater treatment plants (WWTPs) may spread Legionella via the air and cause pneumonia if people inhale them.
WHO Chemical Risk Assessment Workshop on new and emerging risks to human health from chemicals RIVM is hosting an international workshop on new and emerging risks from chemicals on 20 and 21 February 2019.
Possible health risks due to exposure to chromium-6 at tROM project Tilburg Research by RIVM shows that the participants in the so-called tROM project, their supervisors and other people involved may have been exposed to chromium-6.
Kick off European Project VITAL: Vaccines and InfecTious diseases in the Ageing popuLation Recently, the EU-sponsored Vaccines and InfecTious diseases in the Ageing popuLation (VITAL) project was launched.
Lyme disease costs EUR 20 million annually The societal costs of Lyme disease have been determined for the Netherlands for the first time. The disease appears to cost nearly EUR 20 million each year.
Slight increase of ammonia emissions In 2015 slightly more ammonia was emitted in the Netherlands than in 2014 and the ceiling set by the European Union was met (128 kilotons).
TIME honours Guus Velders of RIVM TIME has named Professor Guus Velders of RIVM as one of the 100 most influential people in the world.